» Biography

Mehmet Çelik
University of Trakya Medical School


   Dr. Çelik is researcher of the Division of Endocrinology, Diabetes,  and  Metabolism at the University of Trakya Medical School in Edirne, Turkey. His current research interests genetic basis of endocrine diseases, particularly those involving the thyroid and parathyroid glands as well as obesity and neuroendocrine regulation of food intake and body weight, molecular basis of insulin resistance and type 2 diabetes, Gaucher’s diseasepituitary adenomas. The focus of his work is to understand the pathogenesis and the biology of thyroid cancers with the goal of identifying new molecular-based therapies. He is currently member of Society of Endocrinology and Metabolism of Turkey, and the European Society of Endocrinology.

» Educational Qualifications

» Publications

SCI-SSCI or SCI Expanded Articles

  • .G. TAYLAN, M. AKTOZ, M. ÇELIK, A. M. YILMAZTEPE, Macitentan in the treatment of pulmonary hypertension in Gaucher’xxs disease, The Anatolian Journal of Cardiology, vol. 23, no. 2, pp. 114-116, 2, 2020.
  • .S. M. ERTÜRK, B. ÇEKIÇ, M. ÇELIK, Microwave Ablation of Benign Thyroid Nodules: Effects on Systemic Inflammatory Response, JCPSP-Journal of the College of Physicians and Surgeons Pakistan, vol. 30, no. 7, pp. 694-700, 7, 2020.
  • .M. ÇELIK, B. B. YILMAZ, N. CAN, S. S. AYTÜRK, E. TASTEKIN, A. Y. SEZER, F. ÜSTÜN, S. GÜLDIKEN, Comparison of clinicopathological features in the patients with noninvasive follicular thyroid neoplasm with papillary-like nuclear features and follicular variant papillary thyroid cancer, Polish Archives of Internal Medicine-Polskie Archiwum Medycyny Wewnetrznej, vol. 130, no. 2, pp. 100-105, 1, 2020.
  • .I. M. TURAN, M. ÇELIK, S. M. ERTÜRK, Indocyanine green fluorescence angiography-guided transoral endoscopic thyroidectomy and parathyroidectomy: First clinical report, Photodiagnosis and Photodynamic Therapy, vol. 32, no. 102028, 12, 2020.
  • .M. ÇELIK, S. GÜLDIKEN, S. S. AYTÜRK, B. B. YILMAZ, A. KÜÇÜKARDA, N. CAN, E. TASTEKIN, A. Y. SEZER, N. SÜT, A. A. TUGRUL, H. GÜRKAN, H. TOZKIR, B. DEMIRKAN, Urine iodine excretion in patients with papillary thyroid cancer evaluation of the relationship with the presence of BRAF mutation, Journal of Elementology, vol. 25, no. 03, pp. 1019-1028, 7, 2020.
  • .I. ARDAHANLI, M. ÇELIK, Serum Uric Acid Levels among Patients who Died in Recent Year due to Heart Failure with Reduced Ejection Fraction, JCPSP-Journal of the College of Physicians and Surgeons Pakistan, vol. 30, no. 8, pp. 780-784, 8, 2020.

International Articles

  • .M. ÇELIK, B. B. YILMAZ, S. S. AYTÜRK, Y. DÜRMÜS, H. GÜRKAN, N. CAN, E. TASTEKIN, F. ÜSTÜN, A. Y. SEZER, S. GÜLDIKEN, The relation between BRAFV600E mutation and clinicopathological characteristics of papillary thyroid cancer., Medicinski Glasnik, vol. 17, no. 1, pp. 30-34, 2, 2020.

National Articles

  • .I. ARDAHANLI, M. ÇELIK, Comparison of Tp-e interval, QTc interval and Tp-e/QTc ratios between non-diabetic and prediabetic population, Annals of Medical Research, vol. 27, no. 12, pp. 3117-3122, 12, 2020.
  • .S. ÖZÇELIK, M. ÇELIK, A. VURAL, B. AYDIN, The effect of low and high dose empagliflozin on HbA1c and lipid profile in Type 2 Diabetes mellitus: A real world data, Istanbul Kuzey Klinikleri, vol. 7, no. 2, pp. 167-173, 3, 2020.
    2
    ATIF
  • .S. M. ERTÜRK, M. ÇELIK, N. M. KOSAR, Bariatrik cerrahi öncesi Cushing sendromu için tarama testi gerekli midir?, Pamukkale Tip Dergisi, vol. 13, no. 3, pp. 529-533, 9, 2020.

National Conference Proceedings

  • .M. ÇELIK, S. GÜLDIKEN, S. S. AYTÜRK, B. B. YILMAZ, A. KÜÇÜKARDA, N. CAN, E. TASTEKIN, A. Y. SEZER, N. SÜT, A. TUGRUL, H. GÜRKAN, H. TOZKIR, B. DEMIRKAN, PAPILLER TIROID KANSERI SAPTANAN HASTALARDA IDRAR IYOT ATILIMININ BRAF MUTASYONU VARLIGI ILE ILISKISININ DEGERLENDIRILMESI, 3. AYDIN MULTIDISIPLINER ENDOKRIN GÜNLERI, -TÜRKIYE.

Editorial Positions

  • Covid-19 and pharmacologic treatment
  • New Hypothesis: ANTI-PDL1 (Pembrolizumab) as an Immunotherapeutic Agent for Cushing Disease

Referee Positions

  • COGENTPSYCHOLOGY-2019-0253
  • HORM-D-20-00116
  • TAM-20-02-097
  • CBM-2020-0236
  • CCX-20-0058
  • Adrenocortical Crisis Triggered by Levothyroxine in an Unrecognized Autoimmune Polyglandular Syndrome Type-2: A Rare Case Report and Review
  • HMR-2020-06-0206
  • CBM-2020-0250
  • CCX-20-0163
  • HORM-D-20-00185
  • PULM-D-20-00337R1
  • JOSAM-807627
  • JOSAM-819228
  • Submission ID 431eea0b-d0bb-4fea-ad8e-f4ec4f2d3539
  • Calcitriol Inhibits Proliferation and Potentially Induces Apoptosis in B16-F10 Cell
  • CBM-2020-0624
  • IJCP-01-21-0032
  • COGENTMED-2020-0087
  • BalkanMedJ-2020-12-155
  • ECHO-2020-1183.R1